Otolaryngology · Metairie, LA
NPI
1699873141
Since 2006
Specialty
Otolaryngology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4228 Houma Blvd, Suite 110
Metairie, LA, 70006
Phone (504) 455-3434
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
25,510 services
Medicare patients, 2024
881
Average age 75
Drug cost, 2024
$93K
6,094 prescriptions
Company payments, 2025
$39.72
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert G Brousse was code J1010 (injection, methylprednisolone acetate, 1 mg), 19,480 times for 359 patients. In total Robert G Brousse billed 25,510 services in 52 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 19,480 | 359 | $0.10 | $1,943 |
| 99213 Office E&M - Established | Office | 1,301 | 718 | $56.32 | $73K |
| 96372 Injection Administration | Office | 1,217 | 414 | $8.86 | $11K |
| 95165 Treatment - Miscellaneous | Office | 1,085 | 29 | $9.43 | $10K |
| J2010 Injection, lincomycin hcl, up to 300 mg | Office | 702 | 446 | $6.81 | $4,777 |
| 69210 Other Organ Systems | Office | 411 | 340 | $29.65 | $12K |
| 95115 Treatment - Miscellaneous | Office | 343 | 21 | $6.40 | $2,194 |
| J2920 Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 244 | 211 | $2.27 | $554 |
| 99214 Office E&M - Established | Office | 193 | 141 | $83.95 | $16K |
| 99203 Office E&M - New | Office | 126 | 126 | $62.10 | $7,824 |
| 31575 Other Organ Systems | Office | 96 | 68 | $83.80 | $8,045 |
| G0008 Administration of influenza virus vaccine | Office | 55 | 55 | $31.18 | $1,715 |
| 90658 Vaccine Product | Office | 53 | 53 | $21.42 | $1,135 |
| 99204 Office E&M - New | Office | 43 | 43 | $101.87 | $4,380 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 25 | 23 | $5.48 | $137 |
By year: 2022 $233K for 6,924 services; 2023 $224K for 7,330 services; 2024 $165K for 25,510 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 28 | 14 | $16.24 | $455 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert G Brousse prescribed most often to Medicare patients was Fluticasone Propionate, with 1,007 prescriptions and refills. In total Robert G Brousse wrote 6,094 Medicare prescriptions that cost $93K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 1,007 | 1,865 | 420 | $15K |
| Cefuroxime Cefuroxime Axetil | 639 | 639 | 535 | $6,797 |
| Ipratropium Bromide Generic | 508 | 743 | 256 | $13K |
| Azithromycin Generic | 482 | 482 | 370 | $2,017 |
| Cefdinir Generic | 382 | 382 | 331 | $6,465 |
| Prednisone Generic | 322 | 322 | 268 | $553 |
| Doxycycline Hyclate Generic | 287 | 287 | 228 | $1,992 |
| Meclizine Hcl Generic | 232 | 260 | 136 | $1,607 |
| Montelukast Sodium Generic | 228 | 447 | 62 | $1,589 |
| Levothyroxine Sodium Generic | 189 | 495 | 53 | $1,442 |
| Omeprazole Generic | 187 | 354 | 58 | $1,560 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 129 | 147 | 87 | $3,632 |
| Azelastine Hcl Generic | 109 | 176 | 35 | $2,875 |
| Pantoprazole Sodium Generic | 105 | 207 | 34 | $1,059 |
| Clarithromycin Generic | 99 | 99 | 81 | $1,928 |
Brand drugs: - claims; generic drugs: 5,878 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert G Brousse $39.72 ($39.72 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $39.72.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 2 | $39.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.